Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan · Delayed Price · Currency is TWD 36.85
-0.55 (-1.47%)
Apr 17, 2026, 1:30 PM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 4.76 billion as of April 17, 2026. Its market cap has decreased by -31.09% in one year.
Market Cap
4.76B
Enterprise Value
3.73B
Revenue
67.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
36.85
Market Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has decreased from 4.86B to 4.76B, a decrease of -2.03%. That is a compound annual growth rate of -0.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 4.76B | -28.96% |
| Dec 31, 2025 | 6.70B | -1.89% |
| Dec 31, 2024 | 6.83B | -33.79% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
| Feb 22, 2022 | 4.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AnnJi Pharmaceutical | 5.79B |
| Steminent Biotherapeutics | 5.69B |
| Panion & Bf Biotech | 5.57B |
| UnicoCell Biomed | 5.15B |
| OBI Pharma | 4.98B |
| Senhwa Biosciences | 4.87B |
| Formosa Pharmaceuticals | 4.79B |
| Medigen Biotechnology | 4.37B |